×
Pour une meilleure utilisation, nous vous conseillons d’activer Javascript dans votre navigateur.
5-Aminoimidazole-4-Carboxamide Ribonucleotide Formyltransferase/IMP Cyclohydrolase (ATIC) Peptide
ATIC
Reactivité: Mammifères
Hôte: Synthetic
BP, WB, IHC
Aperçu rapide pour 5-Aminoimidazole-4-Carboxamide Ribonucleotide Formyltransferase/IMP Cyclohydrolase (ATIC) Peptide (ABIN936271)
Antigène
ATIC
(5-Aminoimidazole-4-Carboxamide Ribonucleotide Formyltransferase/IMP Cyclohydrolase (ATIC))
Origine
Mammifères
Source
Toutes les hôtes sur ATIC Peptides
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
Détail du produit
(cache)
Type de proteíne
Synthetic
Séquence
YVVVSTEMQS SESKDTSLET RRQLALKAFT HTAQYDEAIS DYFRKQYSKG
Attributs du produit
A synthetic peptide for use as a blocking control in assays to test for specificity of ATIC antibody, Alternative Names: ATIC control peptide, ATIC antibody Blocking Peptide, Anti-ATIC Blocking Peptide, 5-Aminoimidazole-4-Carboxamide Ribonucleotide Formyltransferase/Imp Cyclohydrolase Blocking Peptide, AICAR Blocking Peptide, AICARFT Blocking Peptide, IMPCHASE Blocking Peptide, PURH Blocking Peptide
Alternatives
(show)
Information d'application
(cache)
Indications d'application
Optimal conditions should be determined by the investigator
Restrictions
For Research Use only
Stockage
(cache)
Format
Lyophilized
Reconstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Conseil sur la manipulation
Avoid repeated freeze/thaw cycles.
Stock
-20 °C
Stockage commentaire
Store at -20 °C long term.
Détail du antigène
(cache)
Antigène
ATIC
(5-Aminoimidazole-4-Carboxamide Ribonucleotide Formyltransferase/IMP Cyclohydrolase (ATIC))
Sujet
ATIC is a bifunctional protein requiring dimerization for transformylase activity.
Poids moléculaire
64 kDa
Vus récemment
(cache)
Vous êtes ici:
Page d'accueil
Peptides
5-Aminoimidazole-4-Carboxamide Ribonucleotide Formyltransferase/IMP Cyclohydrolase (ATIC) Peptide (ABIN936271)
Chat with us , powered by LiveChat